Shanghai Pharma: the application for non-public offering of shares has been approved by CSRC

2022-07-13 0 By

Shanghai Pharma (SH 601607, CLOSING price: 19.3 YUAN) announced on The evening of March 14, 2022 that it reviewed the application for 2021 non-public offering of A shares of Shanghai Pharma Group Co., LTD.According to the audit results of the meeting, the company’s application for the non-public offering of A-shares has been approved.The president of Shanghai Pharmaceutical is Zuo Min, male, 61 years old, with a master’s degree.Daoda1997 “stock trend” reminder: 1. In the past 30 days, the holding amount of Shanghai pharmaceutical northbound funds decreased by 6.310,100 shares, accounting for 0.32% of the outstanding shares.2. No institution has conducted research on Shanghai Pharmaceutical in recent 30 days.More stock trend information, please search wechat public number “Daoda number”, reply to “query”, get free query permission!Disclaimer: The content of this article and data are for reference only, do not constitute investment advice, verify before use.Operate accordingly at your own risk.Declaration: The copyright of this article belongs to the original author, if there is a source error or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will promptly deal with.Email address: jpbl@jp.jiupainews.com